REGN vs SEI · P/E 14, rev $14.34B vs P/E 97, rev $313.1M
Regeneron Pharmaceuticals Inc (REGN) versus Solaris Energy Infrastructure, Inc. (SEI) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Solaris Energy Infrastructure, Inc. (SEI) is a oil & gas equipment & services company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SEI revenue for 2024-12-31 was $313.1M. Net income was $28.9M. Revenue was up 6.9% from 2023-12-31 to 2024-12-31. SEI currently screens at market cap $7.59B and trailing P/E 96.8.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SEI currently screens at market cap $7.59B and trailing P/E 96.8.
Not investment advice. Open the REGN and SEI stock pages for the full models.
Not investment advice.